UK to Begin Negotiating Value-Based Pricing Scheme for Brand Drugs Next Month

Drug Industry Daily
A A
Negotiations on the future of the UK’s pricing and reimbursement policies for brand drugs will begin in September, according to a joint statement from the UK’s Department of Health and the Association of the British Pharmaceutical Industry (ABPI).

To View This Article:

Login

Subscribe To Drug Industry Daily